ARTICLE | Clinical News
Aviron regulatory update
July 18, 1994 7:00 AM UTC
Aviron Aviron and the University of Chicago's techology transfer arm, ARCH Development Corp., received U.S. Patent No. 5,328,688 covering genetically engineered herpes simplex viruses (HSV) that may ...